← Leaderboards
Nidhya Navanandan
University Of Colorado Denver
$1,011,152
Attributed
$1,011,152
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $373.6K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,011,152 · 2
By mechanism
K23$822,152 · 1
R03$189,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Donald Ym Leung$75,548,590
- Ernest E Moore$11,236,991
- Halden F Scott$2,091,101
- Ivor S Douglas$1,990,082
- David R Grosshans$9,101,858
Others in their field
Other Rising Stars on “Innovation”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Cyrus Wadia · Activate Global, Inc.$31,489,493
Research focus
InnovationPediatric EmergencyHomeInhalationOscillometryAccountingAcuteEnrollmentChildhoodImproved OutcomeMorbidity - Disease RateMortalityAsthmaAsthma ExacerbationAutomobile DrivingBiologicalChildEmergency Department VisitAccident And Emergency DepartmentBronchodilator AgentsChildhood AsthmaHospitalizationAdrenal Cortex HormonesPhysiological
Grant awards (6)
Environmental Predictors of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$189,000
R03 · FY2025 · HL · contact PI
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$184,608
K23 · FY2025 · HL · contact PI
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$184,470
K23 · FY2024 · HL · contact PI
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$188,658
K23 · FY2023 · HL · contact PI
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$75,600
K23 · FY2023 · HL · contact PI
Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations$188,816
K23 · FY2022 · HL · contact PI